Q8I659 AF NFT

Putative autophagy-related protein 11

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeia7d7dkcwondlanpvdtfjt6uezqdxjyosje2fwfqodnzzt6bxce44/metadata.json
IPFS of structure file: 
bafybeiam6ayqryuvaqd5sfkwxnv6dyabef7d5qpocr6rxiqhwzwqbx2oci/AF-Q8I659-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x6Ed09D80e98fE15DE51C9E7a8896AbF1f2365C3e
First NFT owner address (bech32): 
genesis1dmgfmq8f3ls4meguneag394t78ervhp7h90qf8
Current NFT ID #30894 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
30894
Accession (UniProt):
Q8I659
Name::
Putative autophagy-related protein 11
Experimental Method:
Predicted structure
Sequence source:
PLASMODIUM FALCIPARUM (ISOLATE 3D7)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q8I659 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q8I659|ATG11_PLAF7 Putative autophagy-related protein 11 OS=Plasmodium falciparum (isolate 3D7) OX=36329 GN=ATG11 PE=1 SV=1 MVILGDEKESYTSYCDKNNDILISKQKIEDLKKSIENLLNDKNAHYELNHIKRSLNELDIYTKNKSDLFNNYNLNESLNDSYKDKTFEELKSQLIKQKNLNSCLSLKLKSIHIKLNNLFLKKNEFEKTINNKIKEIELQFLIIQNVTHENKGIPISKELKEQEKHLQNSHENVAIYDTHEIENNDKKKLYTNFHNEEKDHLKCLLEEYSKTLEIYKMGKIQLEFELKCCKEKLNEEIEKNNNYNNKMKSYEIHIDVVKNENCKNLEELNDLKLQLEKTKSENNQNYVKNKILNDEKNNLDKINNDLKIKIKNFKTLLNDAQNKEYILNNFTQKIFNIITYLKNNDEHNFLNDKIHNKLDINQDQIYVQTELYIDIISSSIRNLINFKKTLEERNVELEKVTHEMKELRKELILKKKNYEELRLKLNHLECVERDSVKINSEKEKGEKVIYELKEKLDNDEKIINDLKKKNSYQVYKMKDYEKRENNLINEINKLKLFIEENKMTVERGNEMNNKKLEEMKQKNKELINNLNDISDELKNCIEQVNSVSRNMANVEKEKENIINELQILRMKNDTMRKRISKFVEQEKVLKFKLYTLNNDIFSKNEKLNDMQKKLNDVNEKYKNIVECLNNYKTEHKEQIEKKIERINTLKQNYYYLKKEYDLKNKELEKNIEHGKKLEHELSHCYEENQKLNEEIKRRNSFIKNKDRKIDLLTNIENELLKKKEINNIKLMEKQNVIKNNEQLLKDIKDENEKMNEHVNKLQNELIKRELQNKCISKDIEFCKKEKEDKIKNLEDDLLEKKKCIENLKDELINIKKKMEDKMHMTNEMDLLSNKVEELNRINKTYEKNIVELNNELDVIKKKLNDEEFLKEEEKKKNIDMVYKIKEYEIQIKEKENEIDSLKKNEQNLHVLKNEELNEKEIILKNKYDKEINMIIEQYNKKIQEEKDMLNNKIKSMDQTHKNQIEEMQEENKKELKRLKNVCDMNLQSQILIKENEKHMQEKVEEYKNLLKQKDQELKNIIQEYDERIEIQNKEMEDIVNDCEEKLKQAKINNKKLTTATNMANNNNMLMDENLKEKDKKINDLMKDMEKKKEEINKLVEEKSKLEHSHVKIQNEMSLLVEQNEKLKEEMGLSRIAIKDMEEIKKDMEKYEEEKKKNEEERKKNEEERKKNEEERKKNEEEKKKNEEERKKNEEEKKKLEKDKHQFEEEKERMEIYEHQKEDRKRKDKKKKGHSSDKEEKYNKKEKTKEKSSNILFDEEYIIQLEELRDTGENCFIYLKSLSKELDVIINKLKSKDDALLNDAFNKINLAITSWNIFNEENKEGDNITTVENTATEGNITIDENTTEVEMNNEEVYKIFSVEKYDMLKKEVGEKVECIQKLIG